speb/financial-data huggingface dataset:
Financial ratios for HBANL — annual report dated 2023-12-31
Total revenue: 7360000000
Net income: 1971000000
Capital expenditures: 1751000000
Operating cash flow: 2657000000
Depreciation & amortization: 798000000
Net tangible assets: 13120000000
Owner earnings: 1018000000
Return on net tangible assets (%): 7.759146341463414
Buffett classification: The Gruesome
Stock price: 19.97
Book value: 19398000000
Debt to equity: 0.6390349520569131
Effective tax rate (%): 17.323825503355707
COGS to revenue (%): 0
SG&A to revenue (%): 40.02717391304348
Free cash flow (dilution-adjusted): 2420000000
Retained earnings: 4322000000
Receivables turnover: 1.0782302959273367
Capitalized R&D asset: 0
FCF margin (%): 32.880434782608695
Revenue growth (%): 1.4612627515853323
Rule of 40 score: 34.341697534194026
Financial ratios for HBANL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.49
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HBANL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.92
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HBANL — annual report dated 2024-12-31
Total revenue: 7385000000
Net income: 1960000000
Capital expenditures: 1626000000
Operating cash flow: 1836000000
Depreciation & amortization: 622000000
Net tangible assets: 13502000000
Owner earnings: 956000000
Return on net tangible assets (%): 7.080432528514294
Buffett classification: The Gruesome
Stock price: 22.92
Book value: 19782000000
Debt to equity: 0.8306035790112223
Effective tax rate (%): 18.435289221806077
COGS to revenue (%): 0
SG&A to revenue (%): 39.688557887610024
Free cash flow (dilution-adjusted): 1587000000
Retained earnings: 5204000000
Receivables turnover: 0.9742744063324539
Capitalized R&D asset: 0
FCF margin (%): 21.489505754908595
Revenue growth (%): 0.33967391304347827
Rule of 40 score: 21.829179667952072
Financial ratios for HBANL — quarterly report dated 2025-03-31
Total revenue: 1920000000
Net income: 531000000
Capital expenditures: 54000000
Operating cash flow: 513000000
Depreciation & amortization: 209000000
Net tangible assets: 14217000000
Owner earnings: 686000000
Return on net tangible assets (%): 4.8252092565238796
Buffett classification: The Gruesome
Stock price: 23.09
Book value: 20486000000
Debt to equity: 0.9093039148686908
Effective tax rate (%): 18.68300153139357
COGS to revenue (%): 0
SG&A to revenue (%): 38.385416666666664
Free cash flow (dilution-adjusted): 438000000
Retained earnings: 5474000000
Receivables turnover: 0.2701561840439004
Capitalized R&D asset: 0
FCF margin (%): 22.8125
Rule of 40 score: 22.8125
Financial ratios for HBANL — quarterly report dated 2025-06-30
Total revenue: 1938000000
Net income: 542000000
Capital expenditures: 686000000
Operating cash flow: 554000000
Depreciation & amortization: 188000000
Net tangible assets: 14720000000
Owner earnings: 44000000
Return on net tangible assets (%): 0.29891304347826086
Buffett classification: The Gruesome
Stock price: 22.66
Book value: 20970000000
Debt to equity: 0.8541726275631855
Effective tax rate (%): 15.047021943573668
COGS to revenue (%): 0
SG&A to revenue (%): 39.73168214654283
Free cash flow (dilution-adjusted): 468000000
Retained earnings: 5751000000
Receivables turnover: 0.2718855218855219
Capitalized R&D asset: 0
FCF margin (%): 24.148606811145513
Revenue growth (%): 0.9375
Rule of 40 score: 25.086106811145513
Financial ratios for HBANL — quarterly report dated 2025-09-30
Total revenue: 2134000000
Net income: 633000000
Capital expenditures: 41000000
Operating cash flow: 487000000
Depreciation & amortization: 175000000
Net tangible assets: 16057000000
Owner earnings: 767000000
Return on net tangible assets (%): 4.776732889082643
Buffett classification: The Gruesome
Stock price: 23.86
Book value: 22286000000
Debt to equity: 0.781791259086422
Effective tax rate (%): 17.362924281984334
COGS to revenue (%): 0
SG&A to revenue (%): 37.488284910965326
Free cash flow (dilution-adjusted): 415000000
Retained earnings: 6123000000
Receivables turnover: 0.29357545742192875
Capitalized R&D asset: 0
FCF margin (%): 19.44704779756326
Revenue growth (%): 10.113519091847266
Rule of 40 score: 29.560566889410527
Financial ratios for HBANL — quarterly report dated 2025-12-31
Total revenue: 2139000000
Net income: 523000000
Capital expenditures: 1738000000
Operating cash flow: 928000000
Depreciation & amortization: 190000000
Net tangible assets: 17593000000
Owner earnings: -1025000000
Return on net tangible assets (%): -5.826180867390439
Buffett classification: The Gruesome
Stock price: 24.52
Book value: 24379000000
Debt to equity: 0.7572090733828295
Effective tax rate (%): 17.11568938193344
COGS to revenue (%): 0
SG&A to revenue (%): 38.61617578307621
Free cash flow (dilution-adjusted): 781000000
Retained earnings: 6351000000
Receivables turnover: 0.2590843023255814
Capitalized R&D asset: 0
FCF margin (%): 36.51238896680692
Revenue growth (%): 0.23430178069353325
Rule of 40 score: 36.74669074750045
Financial ratios for HBANL — annual report dated 2025-12-31
Total revenue: 8131000000
Net income: 2229000000
Capital expenditures: 1589000000
Operating cash flow: 2482000000
Depreciation & amortization: 762000000
Net tangible assets: 17593000000
Owner earnings: 1402000000
Return on net tangible assets (%): 7.969078610811119
Buffett classification: The Gruesome
Stock price: 24.52
Book value: 24379000000
Debt to equity: 0.7572090733828295
Effective tax rate (%): 17.075892857142858
COGS to revenue (%): 0
SG&A to revenue (%): 38.53154593530931
Free cash flow (dilution-adjusted): 2102000000
Retained earnings: 6351000000
Receivables turnover: 0.984859496124031
Capitalized R&D asset: 0
FCF margin (%): 25.851678760300086
Revenue growth (%): 10.10155721056195
Rule of 40 score: 35.95323597086204
Financial ratios for 312A.T — annual report dated 2022-10-31
Total revenue: 29348582.639875516
Gross profit: 4531824.639740207
Operating income: 787700.4262228536
Net income: 367979.16243826534
Capital expenditures: 591353.7649685406
Operating cash flow: 197429.13199377578
Depreciation & amortization: 713246.7356741762
Net tangible assets: -1752763.683106691
Owner earnings: 489872.133143901
Return on net tangible assets (%): -27.94855563618398
Capex to operating income (%): 75.07343468178304
Buffett classification: The Gruesome
Shares outstanding: 480000
Book value: 2886272.917935185
Debt to equity: 5.053919178660169
Current ratio: 1.107999523090873
Quick ratio: 1.101895400023218
Effective tax rate (%): 58.524980174464716
Interest coverage ratio: 6.489604815785072
COGS to revenue (%): 84.55862521421092
Free cash flow (dilution-adjusted): -952811.0412015425
Retained earnings: 2723902.3070157636
Inventory turnover: 314.24355349952884
Receivables turnover: 10.570905005933627
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.950324525987632
FCF margin (%): -3.246531707827591
Rule of 40 score: -3.246531707827591
Financial ratios for 312A.T — annual report dated 2023-10-31
Total revenue: 32999463.48333445
Gross profit: 5297498.491046878
Operating income: 1450177.721145463
Net income: 1054644.2223861578
Capital expenditures: 806055.9318623834
Operating cash flow: 1773925.2900543222
Depreciation & amortization: 765528.8042384816
Net tangible assets: -258554.08758634562
Owner earnings: 1014117.0947622561
Return on net tangible assets (%): -392.22628589214855
Capex to operating income (%): 55.58325163247563
Buffett classification: The Good
Shares outstanding: 480000
Book value: 3915753.4705921784
Debt to equity: 4.5959327119706535
Current ratio: 1.2313228626561048
Quick ratio: 1.2243483348037574
Effective tax rate (%): 36.29395870383349
Interest coverage ratio: 11.190022769612916
COGS to revenue (%): 83.94671327392263
Free cash flow (dilution-adjusted): 952565.2203071557
Retained earnings: 3754798.470927503
Inventory turnover: 279.41825069336403
Receivables turnover: 11.345201423986424
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.565695923444704
FCF margin (%): 2.8866082043673984
Revenue growth (%): 12.439717748067773
Rule of 40 score: 15.326325952435171
Financial ratios for 312A.T — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 811416.4490861619
Buffett classification: The Gruesome
Shares outstanding: 480000
Book value: 4475633.159268931
Debt to equity: 4.043073386935641
Current ratio: 1.214355820469619
Quick ratio: 1.2071341131298097
Retained earnings: 4318975.195822455
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 312A.T — annual report dated 2024-10-31
Total revenue: 31154810.704960838
Gross profit: 5965124.020887729
Operating income: 1602062.6631853788
Net income: 664419.0600522193
Capital expenditures: 1297127.9373368148
Operating cash flow: 4722441.253263708
Depreciation & amortization: 787193.2114882508
Net tangible assets: 811416.4490861619
Owner earnings: 154484.33420365513
Return on net tangible assets (%): 19.038846744805255
Capex to operating income (%): 80.96611743998436
Buffett classification: The Gruesome
Shares outstanding: 480000
Book value: 4475633.159268931
Debt to equity: 4.043073386935641
Current ratio: 1.214355820469619
Quick ratio: 1.2071341131298097
Effective tax rate (%): 57.28105222515067
Interest coverage ratio: 11.87402031930334
COGS to revenue (%): 80.8532811276626
Free cash flow (dilution-adjusted): 3387121.4099216713
Retained earnings: 4318975.195822455
Inventory turnover: 205.83848943887347
Receivables turnover: 9.370125408342757
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.072640417620843
FCF margin (%): 10.871904958749544
Revenue growth (%): -5.589947785985084
Rule of 40 score: 5.281957172764461
Financial ratios for 9158.T — annual report dated 2022-03-31
Total revenue: 289411571.8734634
Gross profit: 116759547.61514506
Operating income: 30150794.95164727
Net income: 22184887.723324046
Capital expenditures: 6810358.957547943
Operating cash flow: 54220619.570562206
Depreciation & amortization: 8752663.497787248
Net tangible assets: 19570562.202917553
Owner earnings: 24127192.26356335
Return on net tangible assets (%): 123.28308207705192
Capex to operating income (%): 22.587659690133187
Buffett classification: The Great
Shares outstanding: 29315309
Book value: 79323061.79314867
Debt to equity: 1.539518545304267
Current ratio: 0.7835867204467887
Quick ratio: 0.7811562726238493
Effective tax rate (%): 38.70789618995031
Interest coverage ratio: 36.79
COGS to revenue (%): 59.659058730248624
SG&A to revenue (%): 24.885314606105226
Free cash flow (dilution-adjusted): 47270939.19029667
Retained earnings: 43353548.5985904
Inventory turnover: 448.2553191489362
Receivables turnover: 3.358440323347599
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.223070845404262
FCF margin (%): 16.333465481112306
Rule of 40 score: 16.333465481112306
Financial ratios for 9158.T — annual report dated 2023-03-31
Total revenue: 264339339.33933938
Gross profit: 103423423.42342344
Operating income: 27650150.150150154
Net income: 18190690.690690693
Capital expenditures: 40518018.01801802
Operating cash flow: 17695195.195195198
Depreciation & amortization: 9166666.666666668
Net tangible assets: 31576576.57657658
Owner earnings: -13160660.660660662
Return on net tangible assets (%): -41.67855444602948
Capex to operating income (%): 146.53814824871029
Buffett classification: The Gruesome
Shares outstanding: 29315309
Book value: 89489489.48948953
Debt to equity: 1.7996644295302007
Current ratio: 0.5980272428370127
Quick ratio: 0.5959605448567403
Effective tax rate (%): 33.847000550357734
Interest coverage ratio: 37.2020202020202
COGS to revenue (%): 60.87475149105368
SG&A to revenue (%): 28.443623970462934
Free cash flow (dilution-adjusted): -24219219.219219223
Retained earnings: 57920420.42042042
Inventory turnover: 487.1363636363637
Receivables turnover: 4.273058252427185
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.951245937161428
FCF margin (%): -9.162169838114172
Revenue growth (%): -8.66317555024583
Rule of 40 score: -17.825345388360002
Financial ratios for 9242.T — annual report dated 2021-07-31
Total revenue: 6135983.9137190385
Gross profit: 4877086.189562198
Operating income: 1630180.0566675807
Net income: 1253834.201626908
Capital expenditures: 6461.932181701855
Operating cash flow: 1866739.7861255826
Depreciation & amortization: 93346.12923864364
Net tangible assets: 5032931.176309296
Owner earnings: 1340718.39868385
Return on net tangible assets (%): 26.638917793964623
Capex to operating income (%): 0.3963937698337052
Buffett classification: The Great
Shares outstanding: 1232157
Book value: 5277716.844895348
Debt to equity: 0
Current ratio: 4.4583170686798015
Quick ratio: 4.43341557724176
Effective tax rate (%): 31.91385873746172
COGS to revenue (%): 20.516490947927867
Free cash flow (dilution-adjusted): 1717795.4483136826
Retained earnings: 4549264.2354446575
Inventory turnover: 40.737947352854185
Receivables turnover: 53.217439556084024
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 30.887978733537107
FCF margin (%): 27.995435980087528
Rule of 40 score: 27.995435980087528
Financial ratios for 9696.HK — annual report dated 2021-12-31
Total revenue: 1192757142.857143
Gross profit: 735931554.1601256
Operating income: 656464835.1648351
Net income: 660257613.8147566
Capital expenditures: 157127786.49921507
Operating cash flow: 350536420.722135
Depreciation & amortization: 71935635.79277866
Net tangible assets: 2169882888.5400314
Owner earnings: 575065463.1083202
Return on net tangible assets (%): 26.502142864274266
Capex to operating income (%): 23.93544605626302
Buffett classification: The Great
Shares outstanding: 236145538
Book value: 3107213814.7566724
Debt to equity: 1.102011311905369
Current ratio: 0.5123719022997336
Quick ratio: 0.443148740830029
Effective tax rate (%): 24.61942662715997
Interest coverage ratio: 2.8354243527423058
COGS to revenue (%): 38.2999667143248
R&D to revenue (%): 0.247780198195203
SG&A to revenue (%): 6.561687148083613
Free cash flow (dilution-adjusted): 193407378.33594975
Retained earnings: 132326844.58398744
Inventory turnover: 3.3380659267042607
Receivables turnover: 11.81731973129811
Capitalized R&D asset: 2955416.0125588696
ROCI (R&D-adjusted, %): 12.62344892120067
FCF margin (%): 16.215151549850265
Rule of 40 score: 16.215151549850265
Financial ratios for ALKALI.NS — annual report dated 2022-03-31
Total revenue: 12002624.291177634
Gross profit: 6191691.942502967
Operating income: 992324.9373598839
Net income: 459026.77040749043
Capital expenditures: 377634.1817222735
Operating cash flow: 1476262.6928656206
Depreciation & amortization: 508861.92799683503
Net tangible assets: 6868350.257154161
Owner earnings: 590254.5166820518
Return on net tangible assets (%): 8.59383250100321
Capex to operating income (%): 38.05549649160111
Buffett classification: The Good
Shares outstanding: 10182506
Book value: 6868350.25715416
Debt to equity: 0.34349601691156567
Current ratio: 1.232203787285954
Quick ratio: 0.5550689926831132
Effective tax rate (%): 30.855565046383663
Interest coverage ratio: 2.859727131075894
COGS to revenue (%): 48.41384856931591
R&D to revenue (%): 1.5578596706729266
SG&A to revenue (%): 8.143192563057664
Free cash flow (dilution-adjusted): 1093696.426216537
Retained earnings: 1070433.865224845
Inventory turnover: 1.7145975602638184
Receivables turnover: 6.794107328142845
Capitalized R&D asset: 186984.04325464857
ROCI (R&D-adjusted, %): 13.447986972332085
FCF margin (%): 9.112144141847741
Rule of 40 score: 9.112144141847741
Financial ratios for ALKALI.NS — annual report dated 2023-03-31
Total revenue: 10521961.02314251
Gross profit: 5477040.194884288
Operating income: 684652.862362972
Net income: 354786.84531059687
Capital expenditures: 382911.08404384897
Operating cash flow: 1362923.264311815
Depreciation & amortization: 522898.9037758831
Net tangible assets: 6439354.445797808
Owner earnings: 494774.6650426309
Return on net tangible assets (%): 7.683606628697243
Capex to operating income (%): 55.9277708592777
Buffett classification: The Good
Shares outstanding: 10182506
Book value: 6439354.4457978085
Debt to equity: 0.4505562060336201
Current ratio: 1.1437145912925113
Quick ratio: 0.4743966439244647
Effective tax rate (%): 22.665002920405673
Interest coverage ratio: 2.1748046119322137
COGS to revenue (%): 47.94658350436938
R&D to revenue (%): 1.2898027789450288
SG&A to revenue (%): 4.966006947941374
Free cash flow (dilution-adjusted): 980012.180267966
Retained earnings: 1084226.5529841657
Inventory turnover: 1.4675028344671202
Receivables turnover: 6.309226623039899
Capitalized R&D asset: 260991.85465661943
ROCI (R&D-adjusted, %): 8.933864312746191
Rosenberg metric: -3.821993230970056
FCF margin (%): 9.313968927583744
Revenue growth (%): -12.336162760034624
Rule of 40 score: -3.0221938324508795
Financial ratios for ALKALI.NS — annual report dated 2024-03-31
Total revenue: 9869840.50845425
Gross profit: 5309941.23995683
Operating income: 520218.25158891955
Net income: 135375.94435783668
Capital expenditures: 202482.31202782108
Operating cash flow: 754227.1255546228
Depreciation & amortization: 551457.0092337211
Net tangible assets: 6157297.03801415
Owner earnings: 484350.6415637366
Return on net tangible assets (%): 7.866286758190072
Capex to operating income (%): 38.92256978861713
Buffett classification: The Good
Shares outstanding: 10182506
Book value: 6157297.038014149
Debt to equity: 0.4448688010875303
Current ratio: 1.1492093874833558
Quick ratio: 0.44452188748335564
Effective tax rate (%): 27.249291054395457
Interest coverage ratio: 1.7464170692431562
COGS to revenue (%): 46.855339798747586
R&D to revenue (%): 1.623603054993281
SG&A to revenue (%): 4.498411996413323
Free cash flow (dilution-adjusted): 546768.1976256146
Retained earnings: 885010.1930687133
Inventory turnover: 1.138588312405337
Receivables turnover: 4.578990119280754
Capitalized R&D asset: 312879.1718951849
ROCI (R&D-adjusted, %): 6.77739878384061
Rosenberg metric: -1.2312712439009457
FCF margin (%): 5.5397875695890635
Revenue growth (%): -6.1977088990726505
Rule of 40 score: -0.6579213294835871
Financial ratios for ALKALI.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 5374354.992833254
Buffett classification: The Gruesome
Shares outstanding: 10182506
Book value: 5374354.992833254
Debt to equity: 0.4885018257949375
Current ratio: 1.0417377483443708
Quick ratio: 0.38370754966887416
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALKALI.NS — quarterly report dated 2024-12-31
Total revenue: 2603753.351206434
Gross profit: 792877.9578039398
Operating income: -353899.05583401327
Net income: -575230.2133115748
Capital expenditures: 0
Depreciation & amortization: 125352.6051987411
Owner earnings: -449877.6081128337
Buffett classification: The Gruesome
Shares outstanding: 10182506
Interest coverage ratio: -6.097810805382607
COGS to revenue (%): 69.54865339159086
R&D to revenue (%): 1.482701812191104
SG&A to revenue (%): 9.373880810830169
Capitalized R&D asset: 38605.8981233244
ROCI (R&D-adjusted, %): -850.0301932367149
Rule of 40 score: 0
Financial ratios for ALKALI.NS — quarterly report dated 2025-03-31
Total revenue: 2904863.2218844984
Gross profit: 1385866.2613981762
Operating income: 301917.23170446575
Net income: 509083.4697217676
Capital expenditures: 0
Depreciation & amortization: 105015.19756838905
Net tangible assets: 5205143.792377834
Owner earnings: 614098.6672901566
Return on net tangible assets (%): 11.797919361793877
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 10182506
Book value: 5205143.792377834
Debt to equity: 0.4073774615495185
Current ratio: 1.0205858466741575
Quick ratio: 0.4266289897315519
Effective tax rate (%): -113.95863017736943
Interest coverage ratio: 6.861317747077578
COGS to revenue (%): 52.98854645406911
R&D to revenue (%): 1.1566230149467567
SG&A to revenue (%): 1.0495730073003275
Retained earnings: 65372.924947393025
Inventory turnover: 0.49323643447152044
Receivables turnover: 1.733260789196504
Capitalized R&D asset: 59464.26831966733
ROCI (R&D-adjusted, %): 5.4928807384221106
Rosenberg metric: 15.360044252822927
Revenue growth (%): 11.564454464880358
Rule of 40 score: 11.564454464880358
Financial ratios for ALKALI.NS — annual report dated 2025-03-31
Total revenue: 9622433.949029693
Gross profit: 3848807.5754033197
Operating income: -535948.0944587328
Net income: -678021.9780219779
Capital expenditures: 95779.75216273087
Operating cash flow: 635667.5239653962
Depreciation & amortization: 484580.3133037175
Net tangible assets: 5205143.792377834
Owner earnings: -289221.4168809913
Return on net tangible assets (%): -5.556453931292224
Buffett classification: The Gruesome
Shares outstanding: 10182506
Book value: 5205143.792377834
Debt to equity: 0.4083095263763116
Current ratio: 1.0205858466741575
Quick ratio: 0.4266289897315519
Interest coverage ratio: -2.0328573962398013
COGS to revenue (%): 60.212148418849154
R&D to revenue (%): 1.5710063017629627
SG&A to revenue (%): 5.962680247794019
Free cash flow (dilution-adjusted): 482604.62941314
Retained earnings: 65372.924947393025
Inventory turnover: 1.8565921819101314
Receivables turnover: 5.741470832374216
Capitalized R&D asset: 303319.6952475293
ROCI (R&D-adjusted, %): -9.02659964622311
Rosenberg metric: -9.118007654502524
FCF margin (%): 5.015411193981798
Revenue growth (%): -2.5066925773788817
Rule of 40 score: 2.5087186166029163
Financial ratios for ALKALI.NS — quarterly report dated 2025-06-30
Total revenue: 2411806.6931897965
Gross profit: 1122010.2972150715
Operating income: 85080.73952726422
Net income: -134916.9201965832
Capital expenditures: 0
Depreciation & amortization: 96349.16920196584
Owner earnings: -38567.75099461737
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 10182506
Effective tax rate (%): 458.5199004975125
Interest coverage ratio: 1.6372438639945956
COGS to revenue (%): 53.47843173404879
R&D to revenue (%): 1.5768049565044417
SG&A to revenue (%): 7.3876950992901955
Capitalized R&D asset: 73280.30596683643
ROCI (R&D-adjusted, %): 117.85657616191803
Rosenberg metric: -7.853249539395538
Revenue growth (%): -16.97348518787872
Rule of 40 score: -16.97348518787872
Financial ratios for ALKALI.NS — quarterly report dated 2025-09-30
Total revenue: 2116527.6211950392
Gross profit: 988410.3720405862
Operating income: -61082.29988726043
Net income: -102976.32468996618
Capital expenditures: 0
Depreciation & amortization: 81341.60090191656
Net tangible assets: 4728816.234498309
Owner earnings: -21634.72378804961
Return on net tangible assets (%): -0.4575082370555448
Buffett classification: The Gruesome
Shares outstanding: 10182506
Book value: 4728816.234498309
Debt to equity: 0.4314619760350557
Current ratio: 1.0227257905898741
Quick ratio: 0.2851810211476107
Interest coverage ratio: -1.2757240404991759
COGS to revenue (%): 53.30037925597648
R&D to revenue (%): 1.3476371074274514
SG&A to revenue (%): 8.223782332637322
Inventory turnover: 0.3539081841974959
Receivables turnover: 2.126356325744705
Capitalized R&D asset: 65090.3126938792
ROCI (R&D-adjusted, %): -1.2789774970570797
Rosenberg metric: -3.5130614170496965
Revenue growth (%): -12.243065450831319
Rule of 40 score: -12.243065450831319
Financial ratios for ELAB — annual report dated 2022-12-31
Total revenue: 766277
Gross profit: 447309
Operating income: -1788292
Net income: -1800268
Capital expenditures: 32027
Operating cash flow: -1585876
Depreciation & amortization: 6512
Net tangible assets: 1131310
Owner earnings: -1825783
Return on net tangible assets (%): -161.38662258797322
Buffett classification: The Gruesome
Shares outstanding: 4543751
Book value: 1131310
Debt to equity: 0.25034429113152007
Current ratio: 2.637082846030408
Quick ratio: 2.245860758288683
Interest coverage ratio: -680.2175732217573
COGS to revenue (%): 41.62567844265194
R&D to revenue (%): 29.85173768754641
SG&A to revenue (%): 225.68535921083367
Free cash flow (dilution-adjusted): -1793272
Retained earnings: -2722373
Inventory turnover: 1.3859436442242934
Receivables turnover: 59.61389450754629
Capitalized R&D asset: 228747
ROCI (R&D-adjusted, %): -106.7292246541629
FCF margin (%): -234.02398871426388
Rule of 40 score: -234.02398871426388
Financial ratios for FCHL — annual report dated 2022-12-31
Total revenue: 2062686.567164179
Gross profit: 891044.776119403
Operating income: 581343.2835820895
Net income: 494776.11940298503
Capital expenditures: 295522.3880597015
Operating cash flow: 923134.3283582089
Depreciation & amortization: 12686.567164179103
Net tangible assets: 194776.11940298506
Owner earnings: 211940.29850746266
Return on net tangible assets (%): 108.81226053639845
Capex to operating income (%): 50.83440308087292
Buffett classification: The Good
Shares outstanding: 1299391
Book value: 194776.1194029851
Debt to equity: 0.9885057471264366
Current ratio: 1.5925925925925926
Quick ratio: 1.5925925925925926
Effective tax rate (%): 17.02127659574468
Interest coverage ratio: 45.8235294117647
COGS to revenue (%): 56.80173661360348
SG&A to revenue (%): 15.231548480463095
Free cash flow (dilution-adjusted): 908955.2238805969
Retained earnings: 186567.16417910447
Receivables turnover: 4.892035398230089
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 186.36363636363635
FCF margin (%): 44.06657018813314
Rule of 40 score: 44.06657018813314
Financial ratios for FCHL — annual report dated 2023-12-31
Total revenue: 3522727.2727272725
Gross profit: 1507575.7575757576
Operating income: 975000
Net income: 846969.6969696969
Capital expenditures: 462878.78787878784
Operating cash flow: 981818.1818181818
Depreciation & amortization: 23484.848484848484
Net tangible assets: 108333.33333333333
Owner earnings: 407575.75757575757
Return on net tangible assets (%): 376.22377622377627
Capex to operating income (%): 47.47474747474747
Buffett classification: The Good
Shares outstanding: 1299391
Book value: 108333.33333333326
Debt to equity: 4.5104895104895135
Current ratio: 0.9663608562691132
Quick ratio: 0.9663608562691132
Effective tax rate (%): 9.473684210526317
Interest coverage ratio: 58.50000000000001
COGS to revenue (%): 57.20430107526882
SG&A to revenue (%): 15.483870967741936
Free cash flow (dilution-adjusted): 518939.3939393939
Retained earnings: 100000
Receivables turnover: 2325
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 201.72413793103453
FCF margin (%): 14.731182795698924
Revenue growth (%): 70.78344954611235
Rule of 40 score: 85.51463234181128
Financial ratios for FCHL — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -31617.647058823528
Buffett classification: The Gruesome
Shares outstanding: 1299391
Book value: 11029.41176470602
Debt to equity: 108.39999999999866
Current ratio: 0.8636596617119426
Quick ratio: 0.8636596617119426
Retained earnings: 2941.176470588235
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FCHL — annual report dated 2024-12-31
Total revenue: 3100000
Gross profit: 1119117.6470588234
Operating income: 124999.99999999999
Net income: 126470.58823529411
Capital expenditures: 24264.70588235294
Operating cash flow: 60294.11764705882
Depreciation & amortization: 61764.70588235294
Net tangible assets: -31617.647058823528
Owner earnings: 163970.5882352941
Return on net tangible assets (%): -518.6046511627907
Capex to operating income (%): 19.411764705882355
Buffett classification: The Great
Shares outstanding: 1299391
Book value: 11029.41176470602
Debt to equity: 108.39999999999866
Current ratio: 0.8636596617119426
Quick ratio: 0.8636596617119426
Effective tax rate (%): -0.584795321637427
Interest coverage ratio: 6.8
COGS to revenue (%): 63.89943074003794
SG&A to revenue (%): 32.779886148007584
Free cash flow (dilution-adjusted): -7352.941176470587
Retained earnings: 2941.176470588235
Receivables turnover: 79.54716981132077
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 41.162227602905546
FCF margin (%): -0.23719165085388993
Revenue growth (%): -11.999999999999995
Rule of 40 score: -12.237191650853884
Financial ratios for FCHL — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -246093.75
Buffett classification: The Gruesome
Shares outstanding: 1299391
Book value: -182031.25
Debt to equity: -8.935622317596566
Current ratio: 0.8026888098062476
Quick ratio: 0.8026888098062476
Retained earnings: -190625
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MRX — annual report dated 2022-12-31
Total revenue: 1416024096.3855422
Gross profit: 594698795.180723
Operating income: 325903614.4578313
Net income: 118313253.0120482
Capital expenditures: 4337349.397590362
Operating cash flow: 271807228.91566265
Depreciation & amortization: 16626506.024096387
Net tangible assets: 598313253.0120482
Owner earnings: 130602409.63855422
Return on net tangible assets (%): 21.828433346757954
Capex to operating income (%): 1.3308687615526802
Buffett classification: The Great
Shares outstanding: 71930870
Book value: 816506024.096386
Debt to equity: 8.453593035266339
Current ratio: 1.0544091087014744
Quick ratio: 1.0519506383095611
Effective tax rate (%): 19.24342105263158
Interest coverage ratio: 1.6393939393939394
COGS to revenue (%): 58.00221220114013
SG&A to revenue (%): 10.218667574236365
Free cash flow (dilution-adjusted): 240361445.78313255
Retained earnings: 548554216.8674699
Inventory turnover: 19.04189944134078
Receivables turnover: 0.13005853906846526
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.884940778341807
FCF margin (%): 16.974389517569985
Rule of 40 score: 16.974389517569985
Financial ratios for MRX — annual report dated 2023-12-31
Total revenue: 2977594936.7088604
Gross profit: 1309873417.721519
Operating income: 858607594.9367088
Net income: 178860759.49367088
Capital expenditures: 11392405.063291138
Operating cash flow: 930379746.835443
Depreciation & amortization: 34303797.46835443
Net tangible assets: 704177215.1898733
Owner earnings: 201772151.89873418
Return on net tangible assets (%): 28.65360417041165
Capex to operating income (%): 1.326846528084918
Buffett classification: The Great
Shares outstanding: 71930870
Book value: 982151898.7341766
Debt to equity: 6.943936074236375
Current ratio: 1.0661831825593182
Quick ratio: 1.0558965545461985
Effective tax rate (%): 28.09160305343511
Interest coverage ratio: 1.442577626541897
COGS to revenue (%): 56.230072694809344
SG&A to revenue (%): 7.741359520469328
Free cash flow (dilution-adjusted): 889367088.607595
Retained earnings: 702911392.4050633
Inventory turnover: 8.094859241126072
Receivables turnover: 0.3050933191527995
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 39.27847588163761
FCF margin (%): 29.868639204183147
Revenue growth (%): 110.27854994200239
Rule of 40 score: 140.14718914618553
Financial ratios for PMI — annual report dated 2022-12-31
Total revenue: 4113000
Gross profit: -4988000
Operating income: -11067000
Net income: -11168000
Capital expenditures: 29000
Operating cash flow: -10723000
Depreciation & amortization: 545000
Net tangible assets: 9983000
Owner earnings: -10652000
Return on net tangible assets (%): -106.70139236702394
Buffett classification: The Gruesome
Shares outstanding: 102695935
Book value: 11369000
Debt to equity: 0.17231066936406017
Current ratio: 4.042347449149717
Quick ratio: 1.5995331777259085
Interest coverage ratio: -2213.4
COGS to revenue (%): 221.2740092389983
R&D to revenue (%): 46.243617797228296
SG&A to revenue (%): 101.55604181862388
Free cash flow (dilution-adjusted): -10900000
Retained earnings: -13217000
Inventory turnover: 1.2422877422877423
Receivables turnover: 1.129324546952224
Capitalized R&D asset: 1902000
ROCI (R&D-adjusted, %): -68.31904064700551
FCF margin (%): -265.01337223437883
Rule of 40 score: -265.01337223437883
Financial ratios for PMI — annual report dated 2023-12-31
Total revenue: 5043000
Gross profit: -2311000
Operating income: -15502000
Net income: -15569000
Capital expenditures: 7000
Operating cash flow: -10634000
Depreciation & amortization: 585000
Net tangible assets: -4851000
Owner earnings: -14991000
Buffett classification: The Gruesome
Shares outstanding: 102695935
Book value: -3552000
Debt to equity: -2.6494932432432434
Current ratio: 0.9510421189752497
Quick ratio: 0.20277898393399912
Interest coverage ratio: -110.72857142857143
COGS to revenue (%): 145.82589728336308
R&D to revenue (%): 43.882609557802894
SG&A to revenue (%): 217.6878841959151
Free cash flow (dilution-adjusted): -10774000
Retained earnings: -28786000
Inventory turnover: 1.0668794429131003
Receivables turnover: 6.805668016194332
Capitalized R&D asset: 3487340
ROCI (R&D-adjusted, %): -259.5111405344105
Rosenberg metric: 1.407465825446898
FCF margin (%): -213.642673012096
Revenue growth (%): 22.61123267687819
Rule of 40 score: -191.0314403352178
Financial ratios for PMI — annual report dated 2024-12-31
Total revenue: 4391000
Gross profit: -112000
Operating income: -13712000
Net income: -21055000
Capital expenditures: 0
Operating cash flow: -11874000
Depreciation & amortization: 543000
Net tangible assets: -24947000
Owner earnings: -20512000
Buffett classification: The Gruesome
Shares outstanding: 102695935
Book value: -23736000
Debt to equity: -0.8816565554432086
Current ratio: 0.27716914366595896
Quick ratio: 0.04744515215852795
Interest coverage ratio: -4.47081838930551
COGS to revenue (%): 102.5506718287406
R&D to revenue (%): 76.97563197449328
SG&A to revenue (%): 232.74880437258028
Free cash flow (dilution-adjusted): -12760000
Retained earnings: -49841000
Inventory turnover: 0.5548983364140481
Receivables turnover: 7.0256
Capitalized R&D asset: 5490370
Rosenberg metric: 0.9936737460460913
FCF margin (%): -290.59439763151903
Revenue growth (%): -12.928812214951419
Rule of 40 score: -303.5232098464704
Financial ratios for PMI — quarterly report dated 2025-03-31
Total revenue: 620000
Gross profit: -358000
Operating income: -3246000
Net income: -5561000
Capital expenditures: 0
Operating cash flow: -2241000
Depreciation & amortization: 129000
Net tangible assets: -29846000
Owner earnings: -5432000
Buffett classification: The Gruesome
Shares outstanding: 102695935
Book value: -28657000
Debt to equity: -0.7960707680496911
Current ratio: 0.24313637720083559
Quick ratio: 0.04312145628170695
Interest coverage ratio: -5.848648648648648
COGS to revenue (%): 157.74193548387098
R&D to revenue (%): 130.32258064516128
SG&A to revenue (%): 335.48387096774195
Free cash flow (dilution-adjusted): -2382000
Retained earnings: -55402000
Inventory turnover: 0.12159641924654979
Receivables turnover: 5.2100840336134455
Capitalized R&D asset: 808000
FCF margin (%): -384.19354838709677
Rule of 40 score: -384.19354838709677
Financial ratios for PMI — quarterly report dated 2025-06-30
Total revenue: 2131000
Gross profit: -127000
Operating income: -3521000
Net income: -6724000
Capital expenditures: 0
Operating cash flow: -2541000
Depreciation & amortization: 126000
Net tangible assets: -35396000
Owner earnings: -6598000
Buffett classification: The Gruesome
Shares outstanding: 102695935
Book value: -34228000
Debt to equity: -0.651104359004324
Current ratio: 0.21130248049785258
Quick ratio: 0.05800245420282233
Interest coverage ratio: -1.4507622579316028
COGS to revenue (%): 105.95964335992491
R&D to revenue (%): 34.8662599718442
SG&A to revenue (%): 124.40168934772406
Free cash flow (dilution-adjusted): -2724000
Retained earnings: -62126000
Inventory turnover: 0.32275586049170957
Receivables turnover: 1.5092067988668556
Capitalized R&D asset: 1284360
Rosenberg metric: 0.28589108910891087
FCF margin (%): -127.82731112153918
Revenue growth (%): 243.70967741935482
Rule of 40 score: 115.88236629781564
Financial ratios for RHLD — annual report dated 2022-12-31
Total revenue: 378476000
Gross profit: 219644000
Operating income: 123681000
Net income: 102694000
Capital expenditures: 9053000
Operating cash flow: 95613000
Depreciation & amortization: 8575000
Net tangible assets: 0
Owner earnings: 102216000
Capex to operating income (%): 7.31963680759373
Buffett classification: The Great
Shares outstanding: 8257442
Book value: -220180000
Debt to equity: -1.6695794350077209
Current ratio: 2.066169404658399
Quick ratio: 1.0751613050839701
Interest coverage ratio: 5.4862047551454936
COGS to revenue (%): 41.966201291495366
SG&A to revenue (%): 25.355108382037432
Free cash flow (dilution-adjusted): 76047000
Retained earnings: -297471000
Inventory turnover: 3.6670745503659408
Receivables turnover: 10.154432281605494
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 94.057568728849
FCF margin (%): 20.09295173273867
Rule of 40 score: 20.09295173273867
Financial ratios for RHLD — annual report dated 2023-12-31
Total revenue: 390629000
Gross profit: 209082000
Operating income: 103855000
Net income: 85701000
Capital expenditures: 10944000
Operating cash flow: 117018000
Depreciation & amortization: 8387000
Net tangible assets: 0
Owner earnings: 83144000
Capex to operating income (%): 10.537769004862549
Buffett classification: The Great
Shares outstanding: 8257442
Book value: -158804000
Debt to equity: -2.1702476008161002
Current ratio: 3.4062445316601253
Quick ratio: 2.092843036772242
Effective tax rate (%): -7.77017680641835
Interest coverage ratio: 4.292593204926841
COGS to revenue (%): 46.47555609030564
SG&A to revenue (%): 26.937836156557758
Free cash flow (dilution-adjusted): 89426000
Retained earnings: -246224000
Inventory turnover: 3.4554054054054055
Receivables turnover: 9.648019166172693
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 59.68540953081538
FCF margin (%): 22.892821577507046
Revenue growth (%): 3.211035838467961
Rule of 40 score: 26.103857415975007
Financial ratios for RHLD — annual report dated 2024-12-31
Total revenue: 420571000
Gross profit: 219227000
Operating income: 126547000
Net income: 110146000
Capital expenditures: 7410000
Operating cash flow: 152101000
Depreciation & amortization: 9174000
Net tangible assets: -790000
Owner earnings: 111910000
Return on net tangible assets (%): -14165.822784810127
Capex to operating income (%): 5.855531936750773
Buffett classification: The Great
Shares outstanding: 8257442
Book value: -36630000
Debt to equity: -5.504777504777505
Current ratio: 3.322185661581414
Quick ratio: 2.4026722504736266
Effective tax rate (%): -0.021794010279508183
Interest coverage ratio: 6.271844179015711
COGS to revenue (%): 47.8739618280861
SG&A to revenue (%): 22.036707238492433
Free cash flow (dilution-adjusted): 123762000
Retained earnings: -2334000
Inventory turnover: 4.366696306577891
Receivables turnover: 8.86364306940083
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 83.44840319953576
FCF margin (%): 29.42713596515214
Revenue growth (%): 7.665073509647261
Rule of 40 score: 37.092209474799404
Financial ratios for RHLD — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -2358173000
Net income: -2333618000
Capital expenditures: 2628000
Operating cash flow: -497808000
Depreciation & amortization: 2242000
Net tangible assets: -36517000
Owner earnings: -2334004000
Buffett classification: The Gruesome
Shares outstanding: 8257442
Book value: -36517000
Debt to equity: -5.521811758906811
Current ratio: 3.3308070708686612
Quick ratio: 2.40877459606463
Interest coverage ratio: -530.1647931654676
Free cash flow (dilution-adjusted): -1544061000
Retained earnings: -201621000
Inventory turnover: 1.0480600316641002
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1553.8831049024775
Rule of 40 score: 0
Financial ratios for SZ50.DE — annual report dated 2021-12-31
Total revenue: 0
Gross profit: 565351.1818181818
Operating income: -353037.4545454546
Net income: -1120317.8181818181
Capital expenditures: 0
Depreciation & amortization: 828.4090909090909
Net tangible assets: -127471.06818181818
Owner earnings: -1119489.409090909
Buffett classification: The Gruesome
Shares outstanding: 1089000
Book value: -127471.06818181742
Debt to equity: 0
Current ratio: 0.13403133710264917
Quick ratio: 0.13403133710264917
Interest coverage ratio: -6.859955087341211
Retained earnings: -6641107.431818182
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -239.28058309750986
Rule of 40 score: 0
Financial ratios for SZ50.DE — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 12918.648936170213
Operating income: -632742.9361702128
Net income: -672083
Capital expenditures: 0
Depreciation & amortization: 454.2553191489362
Net tangible assets: -83438.89361702128
Owner earnings: -671628.7446808511
Buffett classification: The Gruesome
Shares outstanding: 1089000
Book value: -83438.89361702092
Debt to equity: 0
Current ratio: 0.21436928342959022
Quick ratio: 0.21436928342959022
Interest coverage ratio: -34.862094533169135
Retained earnings: -6889289.957446809
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -410.7350491284045
Rule of 40 score: 0
Financial ratios for SZ50.DE — annual report dated 2023-12-31
Total revenue: 0
Operating income: -797603.4333333332
Net income: -493338.99999999994
Capital expenditures: 0
Depreciation & amortization: 473.34444444444443
Net tangible assets: 19828402.599999998
Owner earnings: -492865.6555555555
Return on net tangible assets (%): -2.4856548734569044
Buffett classification: The Gruesome
Shares outstanding: 1089000
Book value: 19828402.6
Debt to equity: 0
Current ratio: 0.21305729401642468
Quick ratio: 0.21305729401642468
Interest coverage ratio: -25.279672250305143
Retained earnings: -782152.9555555555
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.973262650064049
Rule of 40 score: 0
Financial ratios for TAND.L — annual report dated 2021-12-31
Total revenue: 1379729.7297297297
Gross profit: 874324.3243243244
Operating income: 13513.513513513513
Net income: 31081.08108108108
Capital expenditures: 17567.567567567567
Operating cash flow: 109459.45945945947
Depreciation & amortization: 44594.59459459459
Net tangible assets: 289189.1891891892
Owner earnings: 58108.108108108114
Return on net tangible assets (%): 20.093457943925237
Capex to operating income (%): 130
Buffett classification: The Gruesome
Shares outstanding: 73223800
Book value: 289189.18918918923
Debt to equity: 1.1074766355140186
Current ratio: 1.6792452830188678
Quick ratio: 1.512578616352201
Effective tax rate (%): -360
Interest coverage ratio: 2
COGS to revenue (%): 36.6307541625857
SG&A to revenue (%): 62.48775710088149
Free cash flow (dilution-adjusted): 91891.8918918919
Retained earnings: -1825675.6756756757
Inventory turnover: 7.0566037735849045
Receivables turnover: 4.478070175438597
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.481389578163772
FCF margin (%): 6.660137120470128
Rule of 40 score: 6.660137120470128
Financial ratios for TAND.L — annual report dated 2022-12-31
Total revenue: 1898772.2891566267
Gross profit: 1169438.5542168675
Operating income: 342349.3975903615
Net income: 340314.4578313253
Capital expenditures: 46783.132530120485
Operating cash flow: 252254.2168674699
Depreciation & amortization: 45861.445783132534
Net tangible assets: 452330.1204819277
Owner earnings: 339392.7710843373
Return on net tangible assets (%): 75.03209618734584
Capex to operating income (%): 13.6653176139363
Buffett classification: The Great
Shares outstanding: 73223800
Book value: 598443.3734939758
Debt to equity: 0.3774712708472584
Current ratio: 1.7859442214280923
Quick ratio: 1.2107935656322752
Effective tax rate (%): -1.448489376068499
Interest coverage ratio: 49.563928135356704
COGS to revenue (%): 38.41080571402827
SG&A to revenue (%): 43.55915458371643
Free cash flow (dilution-adjusted): 59357.83132530121
Retained earnings: -1287272.2891566267
Inventory turnover: 2.520913671761129
Receivables turnover: 5.688086275160882
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 44.827733087647175
FCF margin (%): 3.1261163681541846
Revenue growth (%): 37.61914730420213
Rule of 40 score: 40.745263672356316
Financial ratios for BWBBP — annual report dated 2022-12-31
Total revenue: 135343000
Net income: 53392000
Capital expenditures: 1633000
Operating cash flow: 84999000
Depreciation & amortization: 3253000
Net tangible assets: 391150000
Owner earnings: 55012000
Return on net tangible assets (%): 14.064169755848141
Buffett classification: The Gruesome
Book value: 394064000
Debt to equity: 0.4812796906086321
Effective tax rate (%): 25.544554455445546
COGS to revenue (%): 0
SG&A to revenue (%): 29.80427506409641
Free cash flow (dilution-adjusted): 80026000
Retained earnings: 248685000
Receivables turnover: 10.041026782402255
Capitalized R&D asset: 0
FCF margin (%): 59.128288866066214
Rule of 40 score: 59.128288866066214
Financial ratios for BWBBP — annual report dated 2023-12-31
Total revenue: 109767000
Net income: 39960000
Capital expenditures: 2970000
Operating cash flow: 30015000
Depreciation & amortization: 3143000
Net tangible assets: 422701000
Owner earnings: 40133000
Return on net tangible assets (%): 9.49441804017497
Buffett classification: The Gruesome
Book value: 425515000
Debt to equity: 0.9695028377378001
Effective tax rate (%): 23.91759643577929
COGS to revenue (%): 0
SG&A to revenue (%): 37.67707963231208
Free cash flow (dilution-adjusted): 23091000
Retained earnings: 280650000
Receivables turnover: 6.574055219500509
Capitalized R&D asset: 0
FCF margin (%): 21.036377053212714
Revenue growth (%): -18.897172369461295
Rule of 40 score: 2.1392046837514194
Financial ratios for BWBBP — annual report dated 2024-12-31
Total revenue: 107740000
Net income: 32825000
Capital expenditures: 4080000
Operating cash flow: 46376000
Depreciation & amortization: 3005000
Net tangible assets: 438103000
Owner earnings: 31750000
Return on net tangible assets (%): 7.2471542080287055
Buffett classification: The Gruesome
Book value: 457935000
Debt to equity: 0.9890486641117189
Effective tax rate (%): 23.191220516660426
COGS to revenue (%): 0
SG&A to revenue (%): 40.846482272136626
Free cash flow (dilution-adjusted): 38391000
Retained earnings: 309421000
Receivables turnover: 1.7376858811006097
Capitalized R&D asset: 0
FCF margin (%): 35.63300538333024
Revenue growth (%): -1.846638789435805
Rule of 40 score: 33.786366593894435
Financial ratios for BWBBP — quarterly report dated 2025-03-31
Total revenue: 31836000
Net income: 9633000
Capital expenditures: 536000
Operating cash flow: 7121000
Depreciation & amortization: 1425000
Net tangible assets: 449373000
Owner earnings: 10522000
Return on net tangible assets (%): 2.341484690891531
Buffett classification: The Gruesome
Book value: 468975000
Debt to equity: 0.9446473692627538
Effective tax rate (%): 23.855821674175953
COGS to revenue (%): 0
SG&A to revenue (%): 38.158060057796206
Free cash flow (dilution-adjusted): 5599000
Retained earnings: 318041000
Receivables turnover: 0.5163320250413571
Capitalized R&D asset: 0
FCF margin (%): 17.587008418142982
Rule of 40 score: 17.587008418142982
Financial ratios for BWBBP — quarterly report dated 2025-06-30
Total revenue: 35707000
Net income: 11520000
Capital expenditures: 1166000
Operating cash flow: 4338000
Depreciation & amortization: 571000
Net tangible assets: 456910000
Owner earnings: 10925000
Return on net tangible assets (%): 2.391061697051936
Buffett classification: The Gruesome
Book value: 476282000
Debt to equity: 1.1063592577506602
Effective tax rate (%): 23.90011890606421
COGS to revenue (%): 0
SG&A to revenue (%): 35.14156888005153
Free cash flow (dilution-adjusted): 2119000
Retained earnings: 328547000
Receivables turnover: 0.5710561668372569
Capitalized R&D asset: 0
FCF margin (%): 5.934410619766433
Revenue growth (%): 12.15919085312225
Rule of 40 score: 18.093601472888682
Financial ratios for BWBBP — quarterly report dated 2025-09-30
Total revenue: 35843000
Net income: 11601000
Capital expenditures: 1601000
Operating cash flow: 9376000
Depreciation & amortization: 994000
Net tangible assets: 478321000
Owner earnings: 10994000
Return on net tangible assets (%): 2.2984564758812596
Buffett classification: The Gruesome
Book value: 497463000
Debt to equity: 1.0314093711492112
Effective tax rate (%): 23.15182829888712
COGS to revenue (%): 0
SG&A to revenue (%): 38.116229110286525
Free cash flow (dilution-adjusted): 6696000
Retained earnings: 339135000
Receivables turnover: 0.57413102674996
Capitalized R&D asset: 0
FCF margin (%): 18.681471975002093
Revenue growth (%): 0.3808776990506063
Rule of 40 score: 19.0623496740527